Pembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From th…
この記事を読む
「論文メモ」の記事一覧 25ページ
この記事を読む
循環腫瘍DNAが早く消失してもアウトカムは変わらない
Clearing of circulating tumour DNA predicts clinical response to first line tyrosine kinase inhibitors in advanced epide…
この記事を読む
KEYNOTE-189 up date
Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metast…
この記事を読む
根治治療後のフォローはどうすべきか？
Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline. Schneider BJ J Clin Oncol. 2020 Mar 1…
この記事を読む
クライオバイオプシーはEGFR遺伝子変異検出に有利？
Cryobiopsy increases the EGFR detection rate in non-small cell lung cancer. Haentschel M et al. Lung Cancer. 2020 Mar;14…
この記事を読む
TKI+ベバシズマブでT790Mが減る？
Investigation of efficacy and acquired resistance for EGFR-TKI plus bevacizumab as first-line treatment in patients with…
この記事を読む
中等度以上の自然気胸でもドレナージ不要
Conservative versus Interventional Treatment for Spontaneous Pneumothorax. Brown SGA et al. N Engl J Med. 2020 Jan 30;38…
この記事を読む
ALK-TKIはPD後もプラチナ＋ペメトレキセドと併用した方がよい？
Efficacy of Platinum/Pemetrexed Combination Chemotherapy in ALK-Positive NSCLC Refractory to Second-Generation ALK Inhib…
この記事を読む
多発か肺内転移かの鑑別アルゴリズム
A Novel Algorithm to Differentiate Between Multiple Primary Lung Cancers and Intrapulmonary Metastasis in Multiple Lung …
この記事を読む
オシメルチニブ耐性、治療するほど多様化
Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimert…